PUBLICATIONS
Lab of Molecular and Digital Pathology for Theranostics
> PUBLICATIONS > Publications
Integrin β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC.
김민기
2018-07-30
조회수 426
제목 : Integrin β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC.
저널 : Clin Cancer Res.
연권호 : 2018 May 18. doi: 10.1158/1078-0432.CCR-17-3492. [Epub ahead of print]
Lab of Molecular and Digital Pathology for
Theranostics SAIHST, Sungkyunkwan University
Copyright © CGMP. All rights reserved.
